Enhanced anti-tumor activity of the Multi-Leu peptide PACE4 inhibitor transformed into an albumin-bound tumor-targeting prodrugAnna Kwiatkowska(Université de Sherbrooke), Robert Day(Université de Sherbrooke)Scientific ReportsFebruary 14, 201910.1038/s41598-018-37568-6Cited by 11SaveCiteExport RISWatch citationsRelated PapersAn Unbiased Mass Spectrometry Approach Identifies Glypican-3 as an Interactor of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) and Low Density Lipoprotein Receptor (LDLR) in Hepatocellular Carcinoma Cells|Journal of Biological Chemistry|2016|17